BioSpace News Archive

Lone Star Bio

Caris’ Precision Oncology Alliance Welcomes The University of Kentucky Markey Cancer Center

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, announced that The University of Kentucky Markey Cancer Center has joined Caris’ Precision Oncology Alliance™.

April 14, 2022
·
6 min read
Genetown

Be Bio Closes $130 Million Financing to Pioneer Engineered B Cells, a New Class of Cellular Medicines

Be Biopharma, a pioneer in the discovery and development of Engineered B Cell Medicines, announced the closing of a $130 million financing, bringing the total investment in the Company to over $180 million.

April 14, 2022
·
5 min read
BioMidwest

Kraig Biocraft Laboratories Receives $1.5 Million in Capital FundingCompany is in its strongest financial position ever, having raised $8 million in 16 months

Kraig Biocraft Laboratories, Inc. announces that it has received another $1.5 million from YAII PN, Ltd (“YAII”) a fund managed by Yorkville Advisors Global, LP (“Yorkville”).

April 14, 2022
·
2 min read
Bio NC

Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of PSVT

Milestone Pharmaceuticals Inc. today announced that the Company will host a virtual Key Opinion Leader (KOL) event on Thursday, April 21, 2022 at 1:00 p.m. ET.

April 14, 2022
·
5 min read
Business

Expanded Dyad Leadership Model: United Digestive Announces Dr. Neal C. Patel as President

United Digestive, a leading physician practice management company focused on gastroenterology, announced Neal C. Patel, MD as its President.

April 14, 2022
·
2 min read
BioMidwest

First Patients Dosed with Illuccix® - Telix’s Approved Prostate Cancer Imaging Agent

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first commercial doses of its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection.

April 14, 2022
·
9 min read
Pharm Country

U.S. FDA Extends Review of Biologics License Application for REGEN-COV® (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended by three months its review of the Biologics License Application (BLA) for REGEN-COV ®.

April 14, 2022
·
14 min read
Lone Star Bio

Eggschain CEO to Speak on Blockchain Applications in Fertility Treatment at 2022 College of Reproductive Biology Symposium

Eggschain is pleased to share that company founder and CEO Wei Escala will be speaking at the 2022 College of Reproductive Biology (CRB) Symposium.

April 14, 2022
·
3 min read
Business

Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla®

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced Twirla prescription data for the first quarter 2022.

April 14, 2022
·
5 min read
Drug Development

Surface Oncology Announces Initiation of Phase 2 Studies Evaluating SRF388 in Patients with Hepatocellular Carcinoma and Non-Small-Cell Lung Cancer

Surface Oncology today announced the initiation of two Phase 2 clinical studies evaluating SRF388, a potential first-in-class antibody against IL-27.

April 14, 2022
·
6 min read